Loading provider…
Loading provider…
Neuro-ophthalmology Physician in Philadelphia, PA
NPI: 1285634105Primary Practice Location
WILLS EYE HOSPITAL
840 Walnut St, Philadelphia, PA
Primary Employer
Wills Eye Ophthalmology Clinic, Inc
willseye.org
HQ Phone
Get MD Robert's Phone Numberphone_androidMobile
Get MD Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 181 | 183 |
| 2 | 93880Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | 157 | 160 |
| 3 | 92083Measurement of field of vision during daylight conditions | 151 | 163 |
| 4 | 92133Diagnostic imaging of optic nerve of eye | 151 | 164 |
| 5 | 92012Eye and medical examination for diagnosis and treatment, established patient | 130 | 172 |
Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy.
Authors: Jose-Alain Sahel, Nancy Newman, Rustum Karanjia, Mark Moster
Publication Date: 2019-10-05
Authors: Sergott, Robert C, Carelli, Valerio, Newman, Nancy J, Biousse, Valérie, Yu-Wai-Man, Patrick, Vignal-Clermont, Catherine, Josse, Constant, Taiel, Magali, Sahel, José-Alain, Barboni, Piero
Journal: Invest Ophthalmol Vis Sci
OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool.
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine Tablets
Lead Sponsor: Neuro-Ophthalmologic Associates, PC
Collaborators: Mallinckrodt
Intervention / Treatment: DRUG: ACTHAR